PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer

Figure 4

Survival analysis of PMEPA1 CpG site methylation in CC. (a, b) High levels ofcg17482197 and cg08583507 showed a poor prognosis. (c) Low levels of cg12502441 showed a poor prognosis in CC patients.

(a)

(b)

(c)